{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T17:31:57Z","timestamp":1791653517430,"version":"4.3.4"},"reference-count":104,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,5,8]],"date-time":"2023-05-08T00:00:00Z","timestamp":1683504000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,5,8]],"date-time":"2023-05-08T00:00:00Z","timestamp":1683504000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virol J"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Viral hepatitis, the most common cause of inflammatory liver disease, affects hundreds of millions of people worldwide. It is most commonly associated with one of the five nominal hepatitis viruses (hepatitis A\u2013E viruses). HBV and HCV can cause acute infections and lifelong, persistent chronic infections, while HAV and HEV cause self-limiting acute infections. HAV and HEV are predominantly transmitted through the fecal-oral route, while diseases transmitted by the other forms are blood-borne diseases. Despite the success in the treatment of viral hepatitis and the development of HAV and HBV vaccines, there is still no accurate diagnosis at the genetic level for these diseases. Timely diagnosis of viral hepatitis is a prerequisite for efficient therapeutic intervention. Due to the specificity and sensitivity of clustered regularly interspaced short palindromic repeat (CRISPR)\/CRISPR-associated sequences (Cas) technology, it has the potential to meet critical needs in the field of diagnosis of viral diseases and can be used in versatile point-of-care (POC) diagnostic applications to detect viruses with both DNA and RNA genomes. In this review, we discuss recent advances in CRISPR\u2013Cas diagnostics tools and assess their potential and prospects in rapid and effective strategies for the diagnosis and control of viral hepatitis infection.<\/jats:p>","DOI":"10.1186\/s12985-023-02048-5","type":"journal-article","created":{"date-parts":[[2023,5,8]],"date-time":"2023-05-08T09:03:19Z","timestamp":1683536599000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Potential of CRISPR\/Cas system as emerging tools in the detection of viral hepatitis infection"],"prefix":"10.1186","volume":"20","author":[{"given":"Howra","family":"Bahrulolum","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hossein","family":"Tarrahimofrad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh Nouri","family":"Rouzbahani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saghi","family":"Nooraei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehdi Mousavi","family":"Sameh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abbas","family":"Hajizade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gholamreza","family":"Ahmadian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,5,8]]},"reference":[{"key":"2048_CR1","doi-asserted-by":"crossref","unstructured":"Tapper EB, Curry MP. Hepatitis Caused by Other Viruses Handbook of Liver Disease, 2018: p.\u00a078.","DOI":"10.1016\/B978-0-323-47874-8.00006-7"},{"key":"2048_CR2","doi-asserted-by":"crossref","unstructured":"Sarin SK, Kumar M. Viral hepatitis A, in Molecular Pathology of Liver Diseases. Springer; 2011. pp. 527\u201352.","DOI":"10.1007\/978-1-4419-7107-4_36"},{"issue":"7","key":"2048_CR3","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.3390\/v13071327","volume":"13","author":"B Qu","year":"2021","unstructured":"Qu B, Brown RJ. Strategies to inhibit Hepatitis B Virus at the transcript level. Viruses. 2021;13(7):1327.","journal-title":"Viruses"},{"issue":"13","key":"2048_CR4","doi-asserted-by":"publisher","first-page":"589","DOI":"10.12998\/wjcc.v6.i13.589","volume":"6","author":"M Jefferies","year":"2018","unstructured":"Jefferies M, et al. Update on global epidemiology of viral hepatitis and preventive strategies. World J Clin cases. 2018;6(13):589.","journal-title":"World J Clin cases"},{"issue":"9","key":"2048_CR5","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1038\/s41575-020-0332-6","volume":"17","author":"AL Cox","year":"2020","unstructured":"Cox AL, et al. Progress towards elimination goals for viral hepatitis. Nat Reviews Gastroenterol Hepatol. 2020;17(9):533\u201342.","journal-title":"Nat Reviews Gastroenterol Hepatol"},{"key":"2048_CR6","doi-asserted-by":"publisher","first-page":"13","DOI":"10.2147\/HMER.S352568","volume":"14","author":"GF Malik","year":"2022","unstructured":"Malik GF, et al. Viral hepatitis-the road traveled and the journey remaining. Hepatic Medicine: Evidence And Research. 2022;14:13.","journal-title":"Hepatic Medicine: Evidence And Research"},{"key":"2048_CR7","doi-asserted-by":"crossref","unstructured":"Wu J et al. Diagnosis, Treatment, and Prognosis of Viral Hepatitis. Front Med, 2022. 9.","DOI":"10.3389\/fmed.2022.882878"},{"issue":"24","key":"2048_CR8","doi-asserted-by":"publisher","first-page":"2102051","DOI":"10.1002\/advs.202102051","volume":"8","author":"H Kong","year":"2021","unstructured":"Kong H, et al. Advanced nanotheranostics of CRISPR\/Cas for viral hepatitis and hepatocellular carcinoma. Adv Sci. 2021;8(24):2102051.","journal-title":"Adv Sci"},{"issue":"5819","key":"2048_CR9","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1126\/science.1138140","volume":"315","author":"R Barrangou","year":"2007","unstructured":"Barrangou R, et al. CRISPR provides acquired resistance against viruses in prokaryotes. Science. 2007;315(5819):1709\u201312.","journal-title":"Science"},{"issue":"12","key":"2048_CR10","doi-asserted-by":"publisher","first-page":"5429","DOI":"10.1128\/jb.169.12.5429-5433.1987","volume":"169","author":"Y Ishino","year":"1987","unstructured":"Ishino Y, et al. Nucleotide sequence of the iap gene, responsible for alkaline phosphatase isozyme conversion in Escherichia coli, and identification of the gene product. J Bacteriol. 1987;169(12):5429\u201333.","journal-title":"J Bacteriol"},{"issue":"2","key":"2048_CR11","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/s41579-019-0299-x","volume":"18","author":"KS Makarova","year":"2020","unstructured":"Makarova KS, et al. Evolutionary classification of CRISPR\u2013Cas systems: a burst of class 2 and derived variants. Nat Rev Microbiol. 2020;18(2):67\u201383.","journal-title":"Nat Rev Microbiol"},{"issue":"1","key":"2048_CR12","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.jmb.2018.06.029","volume":"431","author":"MR O\u2019Connell","year":"2019","unstructured":"O\u2019Connell MR. Molecular mechanisms of RNA targeting by Cas13-containing type VI CRISPR\u2013Cas systems. J Mol Biol. 2019;431(1):66\u201387.","journal-title":"J Mol Biol"},{"key":"2048_CR13","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.mib.2017.05.008","volume":"37","author":"EV Koonin","year":"2017","unstructured":"Koonin EV, Makarova KS, Zhang F. Diversity, classification and evolution of CRISPR-Cas systems. Curr Opin Microbiol. 2017;37:67\u201378.","journal-title":"Curr Opin Microbiol"},{"issue":"11","key":"2048_CR14","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1038\/nrmicro3569","volume":"13","author":"KS Makarova","year":"2015","unstructured":"Makarova KS, et al. An updated evolutionary classification of CRISPR\u2013Cas systems. Nat Rev Microbiol. 2015;13(11):722\u201336.","journal-title":"Nat Rev Microbiol"},{"issue":"3","key":"2048_CR15","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.molcel.2015.10.008","volume":"60","author":"S Shmakov","year":"2015","unstructured":"Shmakov S, et al. Discovery and functional characterization of diverse class 2 CRISPR-Cas systems. Mol Cell. 2015;60(3):385\u201397.","journal-title":"Mol Cell"},{"issue":"3","key":"2048_CR16","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1038\/nrmicro.2016.184","volume":"15","author":"S Shmakov","year":"2017","unstructured":"Shmakov S, et al. Diversity and evolution of class 2 CRISPR\u2013Cas systems. Nat Rev Microbiol. 2017;15(3):169\u201382.","journal-title":"Nat Rev Microbiol"},{"key":"2048_CR17","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1016\/B978-0-323-04579-7.00154-4","volume-title":"Hepatitis viruses infectious Diseases","author":"JN Zuckerman","year":"2010","unstructured":"Zuckerman JN, Zuckerman AJ. In: Heights M, editor. Hepatitis viruses infectious Diseases. 3 ed. Missouri, USA): Mosby Elsevier; 2010. pp. 1539\u201349.","edition":"3"},{"key":"2048_CR18","doi-asserted-by":"crossref","unstructured":"Tu T, Patel K, Shackel N. Chap. 17-Viral Hepatitis Genomic and, 2017.","DOI":"10.1016\/B978-0-12-800685-6.00017-5"},{"key":"2048_CR19","unstructured":"Jha V et al. Computational Screening of Medicinal Plant Phytochemicals to Discover Potent Inhibitors against Hepatitis B Virus"},{"key":"2048_CR20","doi-asserted-by":"crossref","unstructured":"Manns MP, Maasoumy B. Breakthroughs in hepatitis C research: from discovery to cure. Nature Reviews Gastroenterology & Hepatology; 2022. pp. 1\u201318.","DOI":"10.1038\/s41575-022-00608-8"},{"issue":"1","key":"2048_CR21","doi-asserted-by":"publisher","first-page":"14","DOI":"10.5604\/01.3001.0012.7857","volume":"18","author":"JL Trujillo-Ochoa","year":"2019","unstructured":"Trujillo-Ochoa JL, Viera-Segura O, Fierro NA. Challenges in management of hepatitis a virus epidemiological transition in Mexico. Ann Hepatol. 2019;18(1):14\u201322.","journal-title":"Ann Hepatol"},{"key":"2048_CR22","doi-asserted-by":"crossref","unstructured":"Feld JJ. Chronic viral hepatitis in adults and children: hepatitis B Hepatology: Diagnosis and Clinical Management, 2012: p.\u00a0185.","DOI":"10.1002\/9781118314968.ch13"},{"key":"2048_CR23","doi-asserted-by":"crossref","unstructured":"Sharapov UM. Hepatitis A, Foodborne Infections and Intoxications. 2013,Elsevier. 279\u201386.","DOI":"10.1016\/B978-0-12-416041-5.00018-4"},{"issue":"16","key":"2048_CR24","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.3748\/wjg.v27.i16.1691","volume":"27","author":"D Castaneda","year":"2021","unstructured":"Castaneda D, et al. From hepatitis A to E: a critical review of viral hepatitis. World J Gastroenterol. 2021;27(16):1691.","journal-title":"World J Gastroenterol"},{"issue":"10","key":"2048_CR25","doi-asserted-by":"publisher","first-page":"1900","DOI":"10.3390\/v13101900","volume":"13","author":"M Migueres","year":"2021","unstructured":"Migueres M, Lhomme S, Izopet J. Hepatitis A: epidemiology, high-risk groups, prevention and research on antiviral treatment. Viruses. 2021;13(10):1900.","journal-title":"Viruses"},{"issue":"1","key":"2048_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-018-34927-1","volume":"8","author":"K Michaelis","year":"2018","unstructured":"Michaelis K, et al. Hepatitis A virus infections, immunisations and demographic determinants in children and adolescents, Germany. Sci Rep. 2018;8(1):1\u201310.","journal-title":"Sci Rep"},{"issue":"4","key":"2048_CR27","doi-asserted-by":"publisher","first-page":"780","DOI":"10.3390\/vaccines8040780","volume":"8","author":"MI Mikhailov","year":"2020","unstructured":"Mikhailov MI, et al. Universal single-dose vaccination against hepatitis A in children in a region of high endemicity. Vaccines. 2020;8(4):780.","journal-title":"Vaccines"},{"key":"2048_CR28","doi-asserted-by":"crossref","unstructured":"Gupta S. Viral Hepatitis: Historical Perspective, Etiology, Epidemiology, and Pathophysiology Gupta, S.(primera edici\u00f3n), Studies on Hepatitis Viruses: Life Cycle, Structures, Functions, and Inhibition (p\u00e1gs. 1\u201314). Elsevier, 2018.","DOI":"10.1016\/B978-0-12-813330-9.00001-6"},{"issue":"1","key":"2048_CR29","doi-asserted-by":"publisher","first-page":"48","DOI":"10.3748\/wjg.v13.i1.48","volume":"13","author":"J Beck","year":"2007","unstructured":"Beck J, Nassal M. Hepatitis B virus replication. World J gastroenterology: WJG. 2007;13(1):48.","journal-title":"World J gastroenterology: WJG"},{"issue":"1","key":"2048_CR30","doi-asserted-by":"publisher","first-page":"20","DOI":"10.3390\/pathogens11010020","volume":"11","author":"M Logoida","year":"2021","unstructured":"Logoida M, et al. Comparison of two diagnostic methods for the detection of Hepatitis B virus genotypes in the Slovak Republic. Pathogens. 2021;11(1):20.","journal-title":"Pathogens"},{"issue":"1","key":"2048_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-022-11535-8","volume":"12","author":"HM Kafeero","year":"2022","unstructured":"Kafeero HM, et al. Hepatitis B virus (HBV) serological patterns among the HBsAg negative hospital attendees screened for immunization. Sci Rep. 2022;12(1):1\u201310.","journal-title":"Sci Rep"},{"issue":"1","key":"2048_CR32","doi-asserted-by":"publisher","first-page":"45","DOI":"10.3390\/vaccines10010045","volume":"10","author":"SMF Akbar","year":"2021","unstructured":"Akbar SMF, et al. The Safety and Efficacy of a therapeutic vaccine for chronic Hepatitis B: a Follow-Up study of Phase III Clinical Trial. Vaccines. 2021;10(1):45.","journal-title":"Vaccines"},{"issue":"1","key":"2048_CR33","doi-asserted-by":"publisher","first-page":"14","DOI":"10.2105\/AJPH.89.1.14","volume":"89","author":"GM McQuillan","year":"1999","unstructured":"McQuillan GM, et al. Prevalence of hepatitis B virus infection in the United States: the National Health and Nutrition examination surveys, 1976 through 1994. Am J Public Health. 1999;89(1):14\u20138.","journal-title":"Am J Public Health"},{"key":"2048_CR34","doi-asserted-by":"publisher","unstructured":"Liang T, Hepatitis B. The virus and disease. Hepatology, 49. S13\u2013S21. https:\/\/doi.org\/10.1002\/hep, 2009. 22881.","DOI":"10.1002\/hep"},{"key":"2048_CR35","doi-asserted-by":"crossref","unstructured":"Diogo Dias J, Sarica N, Neuveut C. Early Steps of Hepatitis B Life Cycle: From Capsid Nuclear Import to cccDNA Formation. Viruses, 2021. 13(5).","DOI":"10.3390\/v13050757"},{"key":"2048_CR36","doi-asserted-by":"publisher","first-page":"104824","DOI":"10.1016\/j.antiviral.2020.104824","volume":"180","author":"Y Xia","year":"2020","unstructured":"Xia Y, Guo H. Hepatitis B virus cccDNA: formation, regulation and therapeutic potential. Antiviral Res. 2020;180:104824.","journal-title":"Antiviral Res"},{"issue":"2","key":"2048_CR37","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1111\/j.1440-1797.2009.01268.x","volume":"15","author":"M Edey","year":"2010","unstructured":"Edey M, Barraclough K, Johnson DW. Review article: Hepatitis B and dialysis. Nephrol (Carlton). 2010;15(2):137\u201345.","journal-title":"Nephrol (Carlton)"},{"issue":"12","key":"2048_CR38","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1002\/phar.2340","volume":"39","author":"DJ Smalls","year":"2019","unstructured":"Smalls DJ, et al. Hepatitis B Virus Reactivation: risk factors and current management strategies. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. 2019;39(12):1190\u2013203.","journal-title":"Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy"},{"key":"2048_CR39","doi-asserted-by":"crossref","unstructured":"Syed G, Wyles D, Siddiqui A. Hepat Viruses. 2014.","DOI":"10.1016\/B978-0-12-801238-3.00087-8"},{"issue":"1","key":"2048_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12985-015-0341-1","volume":"12","author":"W Ju","year":"2015","unstructured":"Ju W, et al. Hepatitis C virus genotype and subtype distribution in chinese chronic hepatitis C patients: nationwide spread of HCV genotypes 3 and 6. Virol J. 2015;12(1):1\u20136.","journal-title":"Virol J"},{"issue":"S1","key":"2048_CR41","first-page":"31","volume":"5","author":"P Gupta","year":"2013","unstructured":"Gupta P. Hepatitis C virus and HIV type 1 co-infection. Infect disease Rep. 2013;5(S1):31\u20137.","journal-title":"Infect disease Rep"},{"key":"2048_CR42","doi-asserted-by":"crossref","unstructured":"Zheng Y et al. Global Burden and Changing Trend of Hepatitis C Virus Infection in HIV-Positive and HIV-Negative MSM: A Systematic Review and Meta-Analysis. Front Med, 2021. 8.","DOI":"10.3389\/fmed.2021.774793"},{"issue":"Supplement5","key":"2048_CR43","doi-asserted-by":"publisher","first-page":"S330","DOI":"10.1086\/427475","volume":"40","author":"M Backmund","year":"2005","unstructured":"Backmund M, et al. Hepatitis C virus infection and injection drug users: prevention, risk factors, and treatment. Clin Infect Dis. 2005;40(Supplement5):S330\u20135.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"2048_CR44","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3350\/cmh.2013.19.1.17","volume":"19","author":"CW Kim","year":"2013","unstructured":"Kim CW, Chang K-M. Hepatitis C virus: virology and life cycle. Clin Mol Hepatol. 2013;19(1):17.","journal-title":"Clin Mol Hepatol"},{"key":"2048_CR45","doi-asserted-by":"crossref","unstructured":"Colpitts CC, Tsai P-L, Zeisel MB. Hepatitis C virus entry: An intriguingly complex and highly regulated process International Journal of Molecular Sciences, 2020. 21(6): p.\u00a02091.","DOI":"10.3390\/ijms21062091"},{"issue":"1","key":"2048_CR46","doi-asserted-by":"publisher","first-page":"19","DOI":"10.4103\/0973-6247.126683","volume":"8","author":"E Gupta","year":"2014","unstructured":"Gupta E, Bajpai M, Choudhary A. Hepatitis C virus: screening, diagnosis, and interpretation of laboratory assays. Asian J Transfus Sci. 2014;8(1):19.","journal-title":"Asian J Transfus Sci"},{"issue":"1","key":"2048_CR47","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.virol.2003.10.024","volume":"319","author":"J-J Mu","year":"2004","unstructured":"Mu J-J, et al. The small delta antigen of hepatitis delta virus is an acetylated protein and acetylation of lysine 72 may influence its cellular localization and viral RNA synthesis. Virology. 2004;319(1):60\u201370.","journal-title":"Virology"},{"key":"2048_CR48","doi-asserted-by":"publisher","unstructured":"Sausen DG, et al. Hepatitis B and Hepatitis D Viruses: a Comprehensive Update with an immunological focus. Int J Mol Sci. 2022;23. https:\/\/doi.org\/10.3390\/ijms232415973.","DOI":"10.3390\/ijms232415973"},{"key":"2048_CR49","doi-asserted-by":"crossref","unstructured":"USTIANOWSKI A, K. HANDBOOK OF SYSTEMIC, AUTOIMMUNE, DISEASES. 2020. 16: p.\u00a059\u201382.","DOI":"10.1016\/B978-0-444-64217-2.00004-X"},{"key":"2048_CR50","doi-asserted-by":"crossref","unstructured":"Olivero A, Smedile A. Hepatitis delta virus diagnosis. Seminars in liver disease. 2012.Thieme Medical Publishers.","DOI":"10.1055\/s-0032-1323627"},{"issue":"1","key":"2048_CR51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2334-14-308","volume":"14","author":"J-H Kim","year":"2014","unstructured":"Kim J-H, et al. A systematic review of the epidemiology of hepatitis E virus in Africa. BMC Infect Dis. 2014;14(1):1\u201313.","journal-title":"BMC Infect Dis"},{"key":"2048_CR52","doi-asserted-by":"crossref","unstructured":"Shieh Y, Cromeans T, Sobsey M. VIRUSES| hepatitis viruses transmitted by food, water, and environment 2014.","DOI":"10.1016\/B978-0-12-384730-0.00350-5"},{"key":"2048_CR53","doi-asserted-by":"crossref","unstructured":"Chevaliez S, Pawlotsky J-M. Hepatitis Viruses, Infectious Diseases. 2017,Elsevier. 1417\u201325.","DOI":"10.1016\/B978-0-7020-6285-8.00165-9"},{"key":"2048_CR54","doi-asserted-by":"crossref","unstructured":"Nelson KE, Labrique AB, Kmush BL. Epidemiology of genotype 1 and 2 hepatitis E virus infections. Volume 9. Cold Spring Harbor perspectives in medicine; 2019. p. a031732. 6.","DOI":"10.1101\/cshperspect.a031732"},{"key":"2048_CR55","doi-asserted-by":"publisher","first-page":"634430","DOI":"10.3389\/fmicb.2020.634430","volume":"11","author":"F Nicot","year":"2021","unstructured":"Nicot F, et al. Classification of the zoonotic hepatitis E virus genotype 3 into distinct subgenotypes. Front Microbiol. 2021;11:634430.","journal-title":"Front Microbiol"},{"issue":"11","key":"2048_CR56","doi-asserted-by":"publisher","first-page":"299","DOI":"10.3390\/v8110299","volume":"8","author":"J Hartl","year":"2016","unstructured":"Hartl J, Wehmeyer MH, Pischke S. Acute hepatitis E: two sides of the same coin. Viruses. 2016;8(11):299.","journal-title":"Viruses"},{"key":"2048_CR57","doi-asserted-by":"crossref","unstructured":"Zhao C, Wang Y. Laboratory diagnosis of HEV infection. Hepat E Virus, 2016: p. 191\u2013209.","DOI":"10.1007\/978-94-024-0942-0_11"},{"key":"2048_CR58","doi-asserted-by":"crossref","unstructured":"Talapko J et al. Towards the improved accuracy of hepatitis e diagnosis in vulnerable and target groups: A global perspective on the current state of knowledge and the implications for practice. Healthcare. 2021.MDPI.","DOI":"10.3390\/healthcare9020133"},{"key":"2048_CR59","doi-asserted-by":"publisher","first-page":"355","DOI":"10.3389\/fmicb.2014.00355","volume":"5","author":"T Sime-Ngando","year":"2014","unstructured":"Sime-Ngando T. Environmental bacteriophages: viruses of microbes in aquatic ecosystems. Front Microbiol. 2014;5:355.","journal-title":"Front Microbiol"},{"key":"2048_CR60","unstructured":"CJ B, CR H. and M. FA, - laboratory diagnosis of Virus Diseases. Fenner and White\u2019s Medical Virology; 2017."},{"issue":"17","key":"2048_CR61","doi-asserted-by":"publisher","first-page":"2105904","DOI":"10.1002\/advs.202105904","volume":"9","author":"M Xiao","year":"2022","unstructured":"Xiao M, et al. Virus detection: from state-of-the-Art Laboratories to Smartphone-Based point-of-care testing. Adv Sci. 2022;9(17):2105904.","journal-title":"Adv Sci"},{"issue":"1","key":"2048_CR62","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1186\/s12951-021-01081-2","volume":"19","author":"J Dronina","year":"2021","unstructured":"Dronina J, Samukaite-Bubniene U, Ramanavicius A. Advances and insights in the diagnosis of viral infections. J Nanobiotechnol. 2021;19(1):348.","journal-title":"J Nanobiotechnol"},{"key":"2048_CR63","doi-asserted-by":"publisher","unstructured":"Yuan B, et al. Application of the CRISPR\/Cas System in Pathogen detection: a review. Molecules. 2022;27. https:\/\/doi.org\/10.3390\/molecules27206999.","DOI":"10.3390\/molecules27206999"},{"issue":"6387","key":"2048_CR64","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1126\/science.aat4982","volume":"360","author":"DS Chertow","year":"2018","unstructured":"Chertow DS. Next-generation diagnostics with CRISPR. Science. 2018;360(6387):381\u20132.","journal-title":"Science"},{"issue":"6","key":"2048_CR65","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1016\/j.cell.2017.11.032","volume":"172","author":"F Hille","year":"2018","unstructured":"Hille F, et al. The Biology of CRISPR-Cas: Backward and Forward. Cell. 2018;172(6):1239\u201359.","journal-title":"Cell"},{"issue":"7","key":"2048_CR66","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1038\/s41551-021-00760-7","volume":"5","author":"MM Kaminski","year":"2021","unstructured":"Kaminski MM, et al. CRISPR-based diagnostics. Nat Biomedical Eng. 2021;5(7):643\u201356.","journal-title":"Nat Biomedical Eng"},{"issue":"1","key":"2048_CR67","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/1759-8753-4-12","volume":"4","author":"W Bao","year":"2013","unstructured":"Bao W, Jurka J. Homologues of bacterial TnpB_IS605 are widespread in diverse eukaryotic transposable elements. Mob DNA. 2013;4(1):12.","journal-title":"Mob DNA"},{"issue":"6387","key":"2048_CR68","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1126\/science.aar6245","volume":"360","author":"JS Chen","year":"2018","unstructured":"Chen JS, et al. CRISPR-Cas12a target binding unleashes indiscriminate single-stranded DNase activity. Science. 2018;360(6387):436\u20139.","journal-title":"Science"},{"issue":"3","key":"2048_CR69","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/j.cell.2015.09.038","volume":"163","author":"B Zetsche","year":"2015","unstructured":"Zetsche B, et al. Cpf1 is a single RNA-Guided endonuclease of a class 2 CRISPR-Cas System. Cell. 2015;163(3):759\u201371.","journal-title":"Cell"},{"key":"2048_CR70","doi-asserted-by":"publisher","first-page":"639108","DOI":"10.3389\/fcimb.2021.639108","volume":"11","author":"R Ding","year":"2021","unstructured":"Ding R, et al. CRISPR\/Cas system: a potential technology for the Prevention and Control of COVID-19 and Emerging Infectious Diseases. Front Cell Infect Microbiol. 2021;11:639108.","journal-title":"Front Cell Infect Microbiol"},{"issue":"7\u20138","key":"2048_CR71","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1080\/1061186X.2020.1769637","volume":"28","author":"X Xiang","year":"2020","unstructured":"Xiang X, et al. CRISPR-cas systems based molecular diagnostic tool for infectious diseases and emerging 2019 novel coronavirus (COVID-19) pneumonia. J Drug Target. 2020;28(7\u20138):727\u201331.","journal-title":"J Drug Target"},{"key":"2048_CR72","doi-asserted-by":"publisher","first-page":"986233","DOI":"10.3389\/fbioe.2022.986233","volume":"10","author":"K Chen","year":"2022","unstructured":"Chen K, et al. Research progress of CRISPR-based biosensors and bioassays for molecular diagnosis. Front Bioeng Biotechnol. 2022;10:986233.","journal-title":"Front Bioeng Biotechnol"},{"key":"2048_CR73","doi-asserted-by":"publisher","unstructured":"Puig-Serra P, et al. CRISPR approaches for the diagnosis of Human Diseases. Int J Mol Sci. 2022;23. https:\/\/doi.org\/10.3390\/ijms23031757.","DOI":"10.3390\/ijms23031757"},{"issue":"44","key":"2048_CR74","doi-asserted-by":"publisher","first-page":"39562","DOI":"10.1021\/acsomega.2c04513","volume":"7","author":"J Chakraborty","year":"2022","unstructured":"Chakraborty J, et al. CRISPR\/Cas-Based Biosensor as a New Age Detection Method for pathogenic Bacteria. ACS Omega. 2022;7(44):39562\u201373.","journal-title":"ACS Omega"},{"key":"2048_CR75","doi-asserted-by":"crossref","unstructured":"Lee RA et al. Ultrasensitive CRISPR-based diagnostic for field-applicable detection of Plasmodium species in symptomatic and asymptomatic malaria Proceedings of the National Academy of Sciences, 2020. 117(41): p.\u00a025722\u201325731.","DOI":"10.1073\/pnas.2010196117"},{"issue":"6","key":"2048_CR76","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1038\/s41551-020-0546-5","volume":"4","author":"MM Kaminski","year":"2020","unstructured":"Kaminski MM, et al. A CRISPR-based assay for the detection of opportunistic infections post-transplantation and for the monitoring of transplant rejection. Nat Biomed Eng. 2020;4(6):601\u20139.","journal-title":"Nat Biomed Eng"},{"issue":"51","key":"2048_CR77","doi-asserted-by":"publisher","first-page":"1905311","DOI":"10.1002\/adma.201905311","volume":"31","author":"R Bruch","year":"2019","unstructured":"Bruch R, et al. CRISPR\/Cas13a-Powered Electrochemical Microfluidic Biosensor for Nucleic Acid amplification-free miRNA Diagnostics. Adv Mater. 2019;31(51):1905311.","journal-title":"Adv Mater"},{"issue":"8","key":"2048_CR78","doi-asserted-by":"publisher","first-page":"5278","DOI":"10.1021\/acs.analchem.9b00073","volume":"91","author":"Y Shan","year":"2019","unstructured":"Shan Y, et al. High-fidelity and Rapid quantification of miRNA combining crRNA programmability and CRISPR\/Cas13a trans-cleavage activity. Anal Chem. 2019;91(8):5278\u201385.","journal-title":"Anal Chem"},{"issue":"6387","key":"2048_CR79","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1126\/science.aaq0179","volume":"360","author":"JS Gootenberg","year":"2018","unstructured":"Gootenberg JS, et al. Multiplexed and portable nucleic acid detection platform with Cas13, Cas12a, and Csm6. Science. 2018;360(6387):439\u201344.","journal-title":"Science"},{"issue":"6","key":"2048_CR80","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1038\/s41551-019-0371-x","volume":"3","author":"R Hajian","year":"2019","unstructured":"Hajian R, et al. Detection of unamplified target genes via CRISPR\u2013Cas9 immobilized on a graphene field-effect transistor. Nat Biomedical Eng. 2019;3(6):427\u201337.","journal-title":"Nat Biomedical Eng"},{"issue":"1","key":"2048_CR81","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s12575-020-00135-3","volume":"22","author":"S Jolany vangah","year":"2020","unstructured":"Jolany vangah S, et al. CRISPR-Based diagnosis of Infectious and Noninfectious Diseases. Biol Procedures Online. 2020;22(1):22.","journal-title":"Biol Procedures Online"},{"issue":"5","key":"2048_CR82","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1016\/j.cell.2016.04.059","volume":"165","author":"K Pardee","year":"2016","unstructured":"Pardee K, et al. Rapid, low-cost detection of Zika Virus using Programmable Biomolecular Components. Cell. 2016;165(5):1255\u201366.","journal-title":"Cell"},{"issue":"10","key":"2048_CR83","doi-asserted-by":"publisher","first-page":"2986","DOI":"10.1038\/s41596-019-0210-2","volume":"14","author":"MJ Kellner","year":"2019","unstructured":"Kellner MJ, et al. SHERLOCK: nucleic acid detection with CRISPR nucleases. Nat Protoc. 2019;14(10):2986\u20133012.","journal-title":"Nat Protoc"},{"key":"2048_CR84","doi-asserted-by":"publisher","first-page":"108194","DOI":"10.1016\/j.foodcont.2021.108194","volume":"130","author":"S Wang","year":"2021","unstructured":"Wang S, et al. Rapid nucleic acid detection of Escherichia coli O157:H7 based on CRISPR\/Cas12a system. Food Control. 2021;130:108194.","journal-title":"Food Control"},{"issue":"3","key":"2048_CR85","first-page":"e00745","volume":"59","author":"I Mustafa Mujahed","year":"2021","unstructured":"Mustafa Mujahed I, Makhawi Abdelrafie M. SHERLOCK and DETECTR: CRISPR-Cas Systems as potential Rapid Diagnostic Tools for Emerging Infectious Diseases. J Clin Microbiol. 2021;59(3):e00745\u201320.","journal-title":"J Clin Microbiol"},{"issue":"6387","key":"2048_CR86","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1126\/science.aas8836","volume":"360","author":"C Myhrvold","year":"2018","unstructured":"Myhrvold C, et al. Field-deployable viral diagnostics using CRISPR-Cas13. Science. 2018;360(6387):444\u20138.","journal-title":"Science"},{"key":"2048_CR87","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1038\/s41421-018-0028-z","volume":"4","author":"SY Li","year":"2018","unstructured":"Li SY, et al. CRISPR-Cas12a-assisted nucleic acid detection. Cell Discov. 2018;4:20.","journal-title":"Cell Discov"},{"key":"2048_CR88","doi-asserted-by":"publisher","unstructured":"Kumaran A, et al. Advancements in CRISPR-Based Biosensing for Next-Gen Point of Care Diagnostic Application. Biosensors. 2023;13. https:\/\/doi.org\/10.3390\/bios13020202.","DOI":"10.3390\/bios13020202"},{"issue":"7","key":"2048_CR89","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1016\/j.tibtech.2018.12.005","volume":"37","author":"Y Li","year":"2019","unstructured":"Li Y, et al. CRISPR\/Cas Systems towards Next-Generation Biosensing. Trends Biotechnol. 2019;37(7):730\u201343.","journal-title":"Trends Biotechnol"},{"issue":"6","key":"2048_CR90","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1021\/acssynbio.9b00507","volume":"9","author":"R Aman","year":"2020","unstructured":"Aman R, Mahas A, Mahfouz M. Nucleic acid detection using CRISPR\/Cas Biosensing Technologies. ACS Synth Biol. 2020;9(6):1226\u201333.","journal-title":"ACS Synth Biol"},{"key":"2048_CR91","doi-asserted-by":"publisher","first-page":"113541","DOI":"10.1016\/j.bios.2021.113541","volume":"193","author":"L Yin","year":"2021","unstructured":"Yin L, et al. CRISPR-Cas based virus detection: recent advances and perspectives. Biosens Bioelectron. 2021;193:113541.","journal-title":"Biosens Bioelectron"},{"key":"2048_CR92","doi-asserted-by":"publisher","first-page":"743322","DOI":"10.3389\/fbioe.2021.743322","volume":"9","author":"X Chen","year":"2021","unstructured":"Chen X, et al. A CRISPR-Cas12b-Based platform for Ultrasensitive, Rapid, and highly specific detection of Hepatitis B virus genotypes B and C in clinical application. Front Bioeng Biotechnol. 2021;9:743322.","journal-title":"Front Bioeng Biotechnol"},{"issue":"2","key":"2048_CR93","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1007\/s12072-022-10311-0","volume":"16","author":"X Zhang","year":"2022","unstructured":"Zhang X, et al. CRISPR\/Cas13-assisted hepatitis B virus covalently closed circular DNA detection. Hepatol Int. 2022;16(2):306\u201315.","journal-title":"Hepatol Int"},{"issue":"3","key":"2048_CR94","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.cmi.2020.04.018","volume":"27","author":"S Wang","year":"2021","unstructured":"Wang S, et al. Highly sensitive and specific detection of hepatitis B virus DNA and drug resistance mutations utilizing the PCR-based CRISPR-Cas13a system. Clin Microbiol Infect. 2021;27(3):443\u201350.","journal-title":"Clin Microbiol Infect"},{"key":"2048_CR95","doi-asserted-by":"crossref","unstructured":"Ding R et al. CRISPR\/Cas12-Based Ultra-Sensitive and Specific Point-of-Care Detection of HBV. Int J Mol Sci, 2021. 22(9).","DOI":"10.3390\/ijms22094842"},{"key":"2048_CR96","doi-asserted-by":"publisher","first-page":"111239","DOI":"10.1016\/j.biopha.2021.111239","volume":"136","author":"MU Ashraf","year":"2021","unstructured":"Ashraf MU, et al. CRISPR-Cas13a mediated targeting of hepatitis C virus internal-ribosomal entry site (IRES) as an effective antiviral strategy. Biomed Pharmacother. 2021;136:111239.","journal-title":"Biomed Pharmacother"},{"key":"2048_CR97","doi-asserted-by":"publisher","first-page":"816238","DOI":"10.3389\/fcimb.2022.816238","volume":"12","author":"H Wang","year":"2022","unstructured":"Wang H, et al. Rapid Visual detection of Hepatitis C Virus using reverse transcription recombinase-aided amplification-lateral Flow Dipstick. Front Cell Infect Microbiol. 2022;12:816238.","journal-title":"Front Cell Infect Microbiol"},{"key":"2048_CR98","doi-asserted-by":"crossref","unstructured":"Kham-Kjing N et al. Highly Specific and Rapid Detection of Hepatitis C Virus Using RT-LAMP-Coupled CRISPR-Cas12 Assay. Diagnostics (Basel), 2022. 12(7).","DOI":"10.3390\/diagnostics12071524"},{"issue":"32","key":"2048_CR99","doi-asserted-by":"crossref","first-page":"e202203826","DOI":"10.1002\/anie.202203826","volume":"61","author":"H Li","year":"2022","unstructured":"Li H, et al. Amplification-free detection of SARS-CoV-2 and respiratory Syncytial Virus using CRISPR Cas13a and Graphene Field-Effect Transistors. Angew Chem Int Ed Engl. 2022;61(32):e202203826.","journal-title":"Angew Chem Int Ed Engl"},{"key":"2048_CR100","doi-asserted-by":"publisher","unstructured":"Huang Z, et al. Fluorescence Signal-Readout of CRISPR\/Cas Biosensors for nucleic acid detection. Biosensors. 2022;12. https:\/\/doi.org\/10.3390\/bios12100779.","DOI":"10.3390\/bios12100779"},{"issue":"7","key":"2048_CR101","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1080\/14737159.2021.1922080","volume":"21","author":"P Li","year":"2021","unstructured":"Li P, et al. Applications of the CRISPR-Cas system for infectious disease diagnostics. Expert Rev Mol Diagn. 2021;21(7):723\u201332.","journal-title":"Expert Rev Mol Diagn"},{"key":"2048_CR102","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.clinbiochem.2020.12.011","volume":"89","author":"F Palaz","year":"2021","unstructured":"Palaz F, et al. CRISPR-based tools: alternative methods for the diagnosis of COVID-19. Clin Biochem. 2021;89:1\u201313.","journal-title":"Clin Biochem"},{"issue":"1","key":"2048_CR103","doi-asserted-by":"publisher","first-page":"1682","DOI":"10.1080\/22221751.2020.1793689","volume":"9","author":"X Wang","year":"2020","unstructured":"Wang X, Shang X, Huang X. Next-generation pathogen diagnosis with CRISPR\/Cas-based detection methods. Emerg Microbes Infect. 2020;9(1):1682\u201391.","journal-title":"Emerg Microbes Infect"},{"issue":"24","key":"2048_CR104","doi-asserted-by":"publisher","first-page":"35143","DOI":"10.1007\/s11042-020-09010-5","volume":"81","author":"AU Ibrahim","year":"2022","unstructured":"Ibrahim AU, et al. Futuristic CRISPR-based biosensing in the cloud and internet of things era: an overview. Multimed Tools Appl. 2022;81(24):35143\u201371.","journal-title":"Multimed Tools Appl"}],"container-title":["Virology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-023-02048-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12985-023-02048-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-023-02048-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,12]],"date-time":"2023-12-12T09:11:54Z","timestamp":1702372314000},"score":1,"resource":{"primary":{"URL":"https:\/\/virologyj.biomedcentral.com\/articles\/10.1186\/s12985-023-02048-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,8]]},"references-count":104,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2048"],"URL":"https:\/\/doi.org\/10.1186\/s12985-023-02048-5","relation":{},"ISSN":["1743-422X"],"issn-type":[{"value":"1743-422X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,8]]},"assertion":[{"value":"4 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"91"}}